U.S. Could Make Millions in Gilead HIV Prevention Drug Suit (3)

The U.S. government could get millions from Gilead Sciences Inc. as the result of a recently filed lawsuit that alleges the company infringed government-owned patents for the HIV-prevention drug PrEP.

The Department of Health and Human Services is asserting that Gilead refused to license its patents and has “willfully and deliberatively induced infringement” on the department’s patents, according to the complaint.

The government is seeking retrospective damages and ongoing royalties from the company. The complaint alleges the company has made billions from sales of the drug. The pills can cost as much as $1,700 a bottle and earned the company ...